crease (2.3 percent). The most frequently reported adverse
reactions during the additional 18-week open-label treatment period were
similar to those during the double-blind period and also included upper
respiratory tract infection (4.9 percent), influenza (3.8 percent) and
nausea (3.8 percent). Colesevelam HCl was not observed to have an effect on
growth, sexual maturation, hormone levels or fat-soluble vitamin levels
during the course of the study.
IMPORTANT INFORMATION ABOUT WELCHOL(R) (colesevelam HCl)
Prescription Welchol lowers LDL or "bad" cholesterol in adults, along
with diet and exercise. It can be taken alone or with other
cholesterol-lowering medications known as statins.
Welchol, along with diet and exercise, also lowers blood sugar levels
in adults with type 2 diabetes mellitus when added to other antidiabetic
medications (metformin, sulfonylureas, or insulin).
Ask your doctor if Welchol is right for you.
Welchol is not for everyone, especially those with intestinal blockage,
those with blood triglyceride levels of greater than 500 mg/dL, or a
history of pancreatitis (inflammation of the pancreas) due to high
triglyceride levels.
Welchol has not been determined to prevent heart disease or heart
attacks.
Tell your doctor if you have high triglycerides (greater than 300
mg/dL).
Tell your doctor if you have stomach or intestinal problems, including
gastroparesis (when the stomach takes too long to empty its contents),
abnormal contractions of the digestive system, major gastrointestinal tract
surgery, or if you have trouble swallowing.
Tell your doctor if you have vitamin A, D, E, or K deficiencies.
Welchol has known interactions with glyburide (a drug for diabetes),
levothyroxine (a drug used to treat an underactive thyroid) and certain
oral contraceptives. Welchol has not been studied with all combinations of
drugs and supplements. Please tell your doctor about all medications and
sup
'/>"/>
SOURCE Daiichi Sankyo, Inc. (DSI) Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine technology :1.
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes2.
Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated3.
Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels4.
VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis5.
Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol6.
Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials7.
People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels8.
Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)9.
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol10.
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary11.
Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes